Leadership at Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center is led by a director, a deputy director, and team of associate center directors representing all aspects of the center. A Cancer Clinical Enterprise Committee oversees strategy and decision-making for the clinical operations of the center. Vanderbilt-Ingram Cancer Center is also guided by a volunteer community Board of Overseers and external scientific advisory board.
Executive Leadership Team
- Jennifer A. Pietenpol, Ph.D.
Director, Vanderbilt-Ingram Cancer Center - Theresa M. Keske Sberna, M.P.H.
Chief Business Officer; Deputy Director for Strategy and Analytics - W. Kimryn (Kim) Rathmell, M.D., Ph.D.
Deputy Director for Research Integration and Career Development
Associate Directors
- Jordan D. Berlin, M.D.
Associate Director for Clinical Research - Bill Blot, Ph.D.
Associate Director for Population-Based Research - David K. Cortez, Ph.D.
Associate Director for Basic Science Research - Debra L. Friedman, M.D.
Associate Director for Community Science and Health Outcomes - Catherine Gregor, M.B.A., CCRC, CCRP
Director, Clinical Research Administration - Scott Hiebert, Ph.D.
Associate Director for Shared Resources - Beth Jones, M.A.
- Executive Director of Development
- Michelle Martin-Pozo, Ph.D.
Administrative Director for Partnerships, Education and Operations - Tuya Pal, M.D.
Associate Director for Cancer Health Disparities - Ben Ho Park, M.D., Ph.D.
Associate Director of Translational Research - Xiao-Ou Shu, M.D., Ph.D.
- Associate Director for Global Health
- Julie C. Schaum, M.S.
Associate Director for Research Administration - Yu Shyr, Ph.D.
Associate Director for Quantitative Sciences - Anne Washburn, M.P.H.
Administrative Director for Community Relations and Affiliations
Research Program Leaders
Breast Cancer Research Program
Cancer Epidemiology Research Program
Cancer Health Outcomes and Control Research Program
Gastrointestinal Cancer Research Program
Genome Maintenance Research Program
Host-Tumor Interactions Research Program
Signal Transduction and Chemical Biology Research Program
Translational Research and Interventional Oncology Research Program
Other Key Leaders
- Georgia Wiesner, M.D., M.S.
Director, Clinical and Translational Hereditary Cancer Program
Executive Committee
- Jennifer A. Pietenpol, Ph.D., Chair
- Ronald Alvarez, M.D., M.B.A.
- Dan Beauchamp, M.D.
- Bill Blot, Ph.D.
- David K. Cortez, Ph.D.
- Debra L. Friedman, M.D.
- Scott Hiebert, Ph.D.
- Beth Jones, M.A.
- Michelle Martin-Pozo, Ph.D.
- Harold L. Moses, M.D.
- Ben Ho Park, M.D., Ph.D.
- W. Kimryn (Kim) Rathmell, M.D., Ph.D.
- Ann Richmond, Ph.D.
- Anna L. Rodriguez, M.S.N., M.H.A
- Theresa M. Keske Sberna, M.P.H.
- Julie C. Schaum, M.S.
- Xiao-Ou Shu, M.D., Ph.D.
- Yu Shyr, Ph.D.
- Anne Washburn, M.P.H.
- Mary M. Zutter, M.D.
